Subscribe to STAT+ to access exclusive benefits

Our September STAT+ benefits include discounts, comprehensive data tools, and more ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

www.statnews.com/stat-plus Subscribe to STAT+ and access exclusive benefits this month   JOIN STAT+ MIKE REDDY FOR STAT STAT Investigation — At pioneering center for gene therapy, Jim Wilson presided over toxic, abusive workplace, staffers say By Allison DeAngelis, Adam Feuerstein, and Jason Mast A STAT investigation reveals Jim Wilson’s success has obscured a darker side to his leadership of the Gene Therapy Program, the acclaimed university research center he runs — a style that for years permitted toxicity and mismanagement to roil the workflow of lab experiments and research inside the program’s facilities on the leafy Philadelphia campus. Read more with STAT+ 2022 Update: Ranking biotech's top venture capital firms Which venture capital firms get the best returns? Our latest STAT Report is an update of our most popular report to date, this time with 2021 data. In it, STAT’s Kate Sheridan provides a definitively ranked list of more than a dozen of the biggest names in biotech investment, including Third Rock Ventures, OrbiMed, ARCH Venture Partners, and Flagship Pioneering. Purchase The race for longevity: How scientists — and industry — are seeking to extend healthy lives This report examines the science behind the longevity industry, exploring what we know about the biology of aging and the various types of interventions scientists are studying to help slow or even reverse its corrosive effects. Then, we present the leading companies in the space right now and the status of their drug development efforts. Subscribers can get 20% off all STAT Reports. Purchase Rare Disease Research: A Prescription Date: September 15, 2022 Time: 6 p.m. EST Location: Washington, DC Join us in DC for a discussion exploring what it takes to make treatments for rare diseases a reality. Reporters Ed Silverman and Rachel Cohrs will host a multi-part conversation with speakers, including Congresswoman Robin Kelly and Reenie McCarthy, the CEO of Stealth BioTherapeutics. Stay after the discussion for the cocktail reception. Use code JOIN for 50% off your pass. Sign up 2022 STAT Summit Date: November 15–16, 2022 Location: Boston, MA A multi-year pandemic has brought no end of trials, but also plenty of triumphs. Come for a silo-breaking and solution-focused discussion of the most important topics in health care with some of the industry's greatest minds. Subscribers receive a 20% discount on passes. REGISTER STAT+ Reads In case you missed them, here are some of our favorite STAT+ stories from this past month: How much are patients actually using mental health apps? Research on engagement is elusive by Mario Aguilar For the ‘godfather’ of biotech, saving Biogen is the final act of a singular career by Damian Garde The private equity firms, like Blackstone and KKR, behind 8 of the biggest names in autism therapy by Tara Bannow Bright Health Group heads toward insolvency as it rushes to raise more cash by Bob Herman Novartis reports two children died from acute liver failure after treatment with Zolgensma gene therapy by Ed Silverman Read more Monday, September 12, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser